You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,946,281


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,946,281 protect, and when does it expire?

Patent 8,946,281 protects ACULAR LS and is included in one NDA.

This patent has five patent family members in three countries.

Summary for Patent: 8,946,281
Title:Ketorolac tromethamine compositions for treating or preventing ocular pain
Abstract: Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein.
Inventor(s): Muller; Christopher A. (Foothill Ranch, CA), Cheetham; Janet K. (Laguna Niguel, CA), Kuan; Teresa H. (Placentia, CA), Power; David F. (Trabuco Canyon, CA)
Assignee: Allergan Sales, LLC (Irvine, CA)
Application Number:13/802,076
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,946,281
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,946,281: A Comprehensive Guide

Introduction

When analyzing a patent, understanding its scope, claims, and the broader patent landscape is crucial for inventors, researchers, and business professionals. This article will delve into the details of United States Patent 8,946,281, providing a thorough analysis of its scope, claims, and the surrounding patent landscape.

Understanding the Patent System

Before diving into the specifics of Patent 8,946,281, it is essential to understand the basics of the patent system. The U.S. Patent and Trademark Office (USPTO) is responsible for granting U.S. patents and registering trademarks. Patents are granted for novel and non-obvious inventions, and they provide exclusive rights to the inventor for a specified period[2].

Patent 8,946,281 Overview

To analyze Patent 8,946,281, one must first identify the key elements of the patent, including its title, abstract, claims, and description.

Title and Abstract

The title of the patent provides a brief description of the invention, while the abstract gives a concise summary of the invention's main features.

Claims

The claims section is the most critical part of a patent as it defines the scope of the invention. Claims are statements that describe the invention in precise terms and are used to determine the extent of protection granted by the patent. There are two main types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[1].

Analyzing the Claims of Patent 8,946,281

To analyze the claims of Patent 8,946,281, you would typically follow these steps:

Identify Independent Claims

Independent claims are the broadest claims in the patent and define the core of the invention. These claims should be carefully examined to understand the fundamental aspects of the invention.

Examine Dependent Claims

Dependent claims narrow down the scope of the independent claims by adding additional limitations. These claims can provide insights into the specific embodiments of the invention.

Determine Claim Scope

The scope of the claims is crucial for understanding what is protected by the patent. This involves analyzing the language used in the claims and any limitations or exceptions mentioned.

Patent Landscape Analysis

Understanding the patent landscape surrounding Patent 8,946,281 involves several steps:

Prior Art Search

Conducting a prior art search helps in identifying existing patents and publications that may be relevant to the invention. Tools like the USPTO's Patent Public Search, Global Dossier, and international patent databases such as those provided by the European Patent Office (EPO) and the World Intellectual Property Organization (WIPO) are invaluable for this purpose[1].

Identifying Related Patents

Using tools like the Common Citation Document (CCD) and the Patent Examination Data System (PEDS), you can identify related patents and understand how they interact with Patent 8,946,281. The CCD consolidates prior art cited by multiple offices, providing a comprehensive view of the patent family[1].

Analyzing Competitors

Identifying competitors who hold related patents can provide insights into the market and potential challenges. This can be done by searching patent assignments and changes in ownership through the Patent Assignment Search website[1].

Tools and Resources for Patent Analysis

Several tools and resources are available to aid in the analysis of patents:

USPTO Resources

  • Patent Public Search: A powerful tool for searching prior art and understanding the patent landscape.
  • Global Dossier: Provides access to file histories of related applications from participating IP Offices.
  • Patent and Trademark Resource Centers (PTRCs): Offers local search resources and training in patent search techniques[1].

International Patent Databases

  • European Patent Office (EPO): Provides access to European patent databases through esp@cenet.
  • World Intellectual Property Organization (WIPO): Offers the PATENTSCOPE® Search Service for international patent applications[1].

Statistical Analysis and Trends

For a deeper understanding, statistical analysis can be conducted using datasets such as the Patent Claims Research Dataset provided by the USPTO. This dataset contains detailed information on claims from U.S. patents and can help in identifying trends and patterns in patent scope and claims[3].

Expert Insights and Quotes

Industry experts often provide valuable insights into patent analysis. For example, Alan C. Marco and Joshua D. Sarnoff, in their paper "Patent Claims and Patent Scope," discuss the importance of claim scope in defining the boundaries of patent protection[3].

Illustrative Statistics

  • Patent Scope Measurements: The Patent Claims Research Dataset shows that between 1976 and 2014, there was a significant increase in the complexity of patent claims, indicating a trend towards more detailed and specific claims[3].

Examples and Case Studies

Real-world examples can help illustrate the importance of thorough patent analysis. For instance, the analysis of drug patents, such as those listed in the Orange Book, demonstrates how patent information is crucial for understanding market exclusivity and therapeutic equivalence evaluations[4].

Key Takeaways

  • Thorough Claims Analysis: Understanding the claims of a patent is essential for determining its scope and protection.
  • Prior Art Search: Conducting a comprehensive prior art search is vital for identifying related patents and avoiding infringement.
  • Use of Tools and Resources: Utilizing tools like the USPTO's Patent Public Search and international patent databases can significantly enhance patent analysis.
  • Statistical Trends: Analyzing statistical trends in patent claims can provide insights into broader patent landscape dynamics.

FAQs

Q1: What is the primary purpose of the claims section in a patent? The primary purpose of the claims section is to define the scope of the invention and determine the extent of protection granted by the patent.

Q2: How can I conduct a prior art search for a patent? You can conduct a prior art search using tools like the USPTO's Patent Public Search, Global Dossier, and international patent databases such as those provided by the EPO and WIPO.

Q3: What is the Common Citation Document (CCD) and how is it used? The CCD consolidates prior art cited by multiple offices, providing a single point of access to citation data relating to the patent applications of the IP5 Offices.

Q4: Where can I find statistical data on patent claims? The USPTO provides the Patent Claims Research Dataset, which contains detailed information on claims from U.S. patents granted between 1976 and 2014.

Q5: Why is it important to analyze the patent landscape surrounding a patent? Analyzing the patent landscape helps in understanding related patents, identifying competitors, and avoiding potential infringement issues.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. FDA Orange Book Cumulative Supplement: https://www.drugpatentwatch.com/p/fda-orange-book/supplements/orangebook-ed35-supp08-.pdf

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,946,281

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Abbvie ACULAR LS ketorolac tromethamine SOLUTION/DROPS;OPHTHALMIC 021528-001 May 30, 2003 AT RX Yes Yes ⤷  Subscribe ⤷  Subscribe A METHOD OF TREATING OCULAR PAIN ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,946,281

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2468664 ⤷  Subscribe
Canada 2967362 ⤷  Subscribe
European Patent Office 3217937 ⤷  Subscribe
European Patent Office 3777808 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 2016077726 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.